Leishmaniasis

news report

WHO Cuts East Africa Kala-Azar Regimen to 14 Days

New guidance recommends the first sodium-stibogluconate-free option for many patients and shorter regimens for a related skin condition.

August 11, 2026, 9:12 a.m. CDT